Stephen P Squinto - Net Worth and Insider Trading
Stephen P Squinto Net Worth
The estimated net worth of Stephen P Squinto is at least $25 Million dollars as of 2024-04-25. Stephen P Squinto is the EVP, Chief Global Ops. Officer of Alexion Pharmaceuticals Inc and owns about 106,508 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $19 Million. Stephen P Squinto is also the Director, 10% Owner of SpringWorks Therapeutics Inc and owns about 125,728 shares of SpringWorks Therapeutics Inc (SWTX) stock worth over $5 Million. Details can be seen in Stephen P Squinto's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen P Squinto has not made any transactions after 2021-04-28 and currently still holds the listed stock(s).
Transaction Summary of Stephen P Squinto
Stephen P Squinto Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen P Squinto owns 6 companies in total, including SpringWorks Therapeutics Inc (SWTX) , Passage Bio Inc (PASG) , and Audentes Therapeutics Inc (BOLD) among others .
Click here to see the complete history of Stephen P Squinto’s form 4 insider trades.
Insider Ownership Summary of Stephen P Squinto
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SWTX | SpringWorks Therapeutics Inc | 2021-04-28 | director & 10 percent owner |
| PASG | Passage Bio Inc | 2020-02-27 | director & Head of Research and Dev |
| BOLD | Audentes Therapeutics Inc | 2017-10-08 | director |
| ALXN | Alexion Pharmaceuticals Inc | 2014-10-27 | EVP & Chief Global Ops. Officer |
| CMMB | Chemomab Therapeutics Ltd | 2021-03-16 | director |
| CMPX | Compass Therapeutics Inc | 2020-08-06 | director |
Stephen P Squinto Latest Holdings Summary
Stephen P Squinto currently owns a total of 2 stocks. Among these stocks, Stephen P Squinto owns 106,508 shares of Alexion Pharmaceuticals Inc (ALXN) as of October 27, 2014, with a value of $19 Million and a weighting of 78.09%. Stephen P Squinto also owns 125,728 shares of SpringWorks Therapeutics Inc (SWTX) as of April 28, 2021, with a value of $5 Million and a weighting of 21.91%.
Latest Holdings of Stephen P Squinto
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2014-10-27 | 106,508 | 182.50 | 19,437,710 |
| SWTX | SpringWorks Therapeutics Inc | 2021-04-28 | 125,728 | 43.38 | 5,454,081 |
Holding Weightings of Stephen P Squinto
Stephen P Squinto Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen P Squinto has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 5,910 shares on October 27, 2014, which brought Stephen P Squinto around $1 Million.
According to the SEC Form 4 filings, Stephen P Squinto has made a total of 3 transactions in SpringWorks Therapeutics Inc (SWTX) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in SpringWorks Therapeutics Inc is the sale of 19,432 shares on April 28, 2021, which brought Stephen P Squinto around $1 Million.
Insider Trading History of Stephen P Squinto
- 1
Stephen P Squinto Trading Performance
GuruFocus tracks the stock performance after each of Stephen P Squinto's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen P Squinto is 28.57%. GuruFocus also compares Stephen P Squinto's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen P Squinto within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen P Squinto's insider trading performs compared to the benchmark.
Performance of Stephen P Squinto
Average Return
97.21%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.38 | 28.57 | -7.22 | 97.21 | 78.04 | 6.05 |
| Relative Return to S&P 500(%) | -16.12 | 22.35 | 8.63 | 85.56 | 56.63 | -2.77 |
Stephen P Squinto Ownership Network
Ownership Network List of Stephen P Squinto
Ownership Network Relation of Stephen P Squinto
Stephen P Squinto Owned Company Details
What does SpringWorks Therapeutics Inc do?
Who are the key executives at SpringWorks Therapeutics Inc?
Stephen P Squinto is the director & 10 percent owner of SpringWorks Therapeutics Inc. Other key executives at SpringWorks Therapeutics Inc include Chief People Officer Daniel Pichl , Chief Commercial Officer Bhavesh Ashar , and Chief Scientific Officer Tai-an Lin .
SpringWorks Therapeutics Inc (SWTX) Insider Trades Summary
Over the past 18 months, Stephen P Squinto made no insider transaction in SpringWorks Therapeutics Inc (SWTX). Other recent insider transactions involving SpringWorks Therapeutics Inc (SWTX) include a net sale of 42,039 shares made by Daniel Pichl , a net sale of 4,818 shares made by Julie Hambleton , and a net sale of 1,750,000 shares made by Jeffrey Lawrence Schwartz .
In summary, during the past 3 months, insiders sold 49,237 shares of SpringWorks Therapeutics Inc (SWTX) in total and bought 0 shares, with a net sale of 49,237 shares. During the past 18 months, 1,804,913 shares of SpringWorks Therapeutics Inc (SWTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,913 shares.
SpringWorks Therapeutics Inc (SWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
SpringWorks Therapeutics Inc Insider Transactions
Stephen P Squinto Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen P Squinto. You might contact Stephen P Squinto via mailing address: C/o Alexion Pharmaceuticals Inc, 352 Knotter Drive, Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
